Meet Mark, Program Manager, In Vitro Diagnostic Regulations

Mark Rundell is a program manager of in vitro diagnostic regulations. Here is a peek at what he does and why he likes working for us. Watch the video.
Meet Mark, Program Manager, In Vitro Diagnostic Regulations

Meet your next favorite teammate! Mark Rundell is a program manager of in vitro diagnostic regulations at our Chaska, Minnesota location. Here is a peek at what he does and why he likes working for us.

Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

Get to Know Advantaged Workflows

Get to Know Advantaged Workflows

It takes the right combination of efficiency, accuracy, technology, and clinical expertise to transform a workflow into a unique advantage—and we’re here to help find the right combination for you.
Blood-Based Biomarkers and the Future of Alzheimer’s Disease Diagnostics

Blood-Based Biomarkers and the Future of Alzheimer’s Disease Diagnostics

We sat down with our own Alzheimer’s disease and dementia subject matter expert, Dr. Arindam Ghosh, to learn the potential of blood-based biomarkers to transform the approach to Alzheimer’s disease diagnosis and management.
Exploring the Potential Role of Blood-Based Biomarkers in Identifying and Monitoring Alzheimer's Disease

Exploring the Potential Role of Blood-Based Biomarkers in Identifying and Monitoring Alzheimer's Disease

At the 2024 Clinical Trials in Alzheimer’s Disease (CTAD 2024) conference in Madrid, Spain, discussed the promise of blood-based diagnostic biomarkers.